Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 10, 2026
Sex differences in cirrhosis incidence among untreated chronic hepatitis B patients: a 10-year Chinese cohort studyQiao Tang, Yuan-Hai Zhou, Nan Cai, et al.
Translational Lung Cancer Research|September 29, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment optionsJiu-Wei Cui, Qing Zhou, Shun Lu, et al.
Chinese Medical Journal|May 21, 2020
Association of cardiovascular diseases with milk intake among general Chinese adultsXin-Yan Wang, Fang-Chao Liu, Xue-Li Yang, et al.
Chronic Diseases and Translational Medicine|October 25, 2017
Risk stratification of atherosclerotic cardiovascular disease in Chinese adultsXue-Li Yang, Ji-Chun Chen, Jian-Xin Li, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II studyJin-Ji Yang, Cheng Huang, Yun Fan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2020
[Clinical Characteristics and Bone Marrow Histopathology Features in Essential Thrombocythaemia Patients with Different Gene Mutation in China]Xiu-Peng Ye, Rong Wang, Quan-Gui Wang, et al.
Biomedical and Environmental Sciences : BES|July 8, 2026
Joint Association of Sleep and Physical Activity with Central Obesity in Chinese AdultsYou Jing Zhang, Mei Ling Hu, Zi Yi Yang, et al.
The Lancet. Oncology|July 26, 2011
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyCaicun Zhou, Yi-Long Wu, Gongyan Chen, et al.
Investigational New Drugs|October 14, 2020
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancerJin-Ji Yang, Jian Fang, Yong-Qian Shu, et al.
Oncotarget|May 18, 2017
Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapyLiang-Liang Li, Li-Li Qu, Han-Jiang Fu, et al.
Pageof 28